Marimed (MRMD) Current Deferred Tax Assets (2013 - 2014)

Marimed (MRMD) posted quarterly Current Deferred Tax Assets of $734900.0 for Q1 2014, up 7.53% quarter-over-quarter from $683417.0 in Q4 2013.

Marimed (MRMD) Current Deferred Tax Assets (2013 - 2014) Analysis & Trends

Marimed (MRMD) has reported Current Deferred Tax Assets for 2 consecutive years, with $734900.0 the latest figure, recorded in Q1 2014.

In Q1 2014, Current Deferred Tax Assets changed N/A year-over-year to $734900.0; the TTM figure through Mar 2014 stood at $734900.0 (changed N/A YoY), while the FY2013 annual figure was $683417.0, changed N/A from the prior year.
Current Deferred Tax Assets rose to $734900.0 in Q1 2014 per MRMD's latest filing, from $683417.0 in the prior quarter.
Across five years, Current Deferred Tax Assets topped out at $734900.0 in Q1 2014 and bottomed at $683417.0 in Q4 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-
2	Teva Pharmaceutical Industries	42.98 Bn	39.32 Bn	2.15 Bn
3	Zoetis	31.53 Bn	29.86 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-
10	Marimed	27.77 Mn	19.33 Mn	16.23 Mn

Download Data